huCART19-IL18-CD428z cells / University of Pennsylvania - LARVOL DELTA

huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers (clinicaltrials.gov) - P1 | N=6 | Not yet recruiting | Sponsor: University of Pennsylvania

New P1 trial • Acute Lymphocytic Leukemia • B Cell Lymphoma • Chronic Lymphocytic Leukemia • Chronic Myeloid Leukemia • Follicular Lymphoma • Hematological Malignancies • Human Immunodeficiency Virus • Indolent Lymphoma • Infectious Disease • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Richter's Syndrome • ALK • BCL2 • BCL6 • CD19